Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply to Kadri Altundag: Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage?
Grassadonia A, Vici P, Gamucci T, Moscetti L, Pizzuti L, Mentuccia L, Iezzi L, Scognamiglio MT, Zilli M, Giampietro J, Graziano V, Natoli C, Tinari N. Grassadonia A, et al. Among authors: graziano v. Breast. 2017 Oct;35:218-219. doi: 10.1016/j.breast.2017.05.006. Epub 2017 May 17. Breast. 2017. PMID: 28526175 No abstract available.
Long-term outcome of breast cancer patients with pathologic N3a lymph node stage.
Grassadonia A, Vici P, Gamucci T, Moscetti L, Pizzuti L, Mentuccia L, Iezzi L, Scognamiglio MT, Zilli M, Giampietro J, Graziano V, Natoli C, Tinari N. Grassadonia A, et al. Among authors: graziano v. Breast. 2017 Apr;32:79-86. doi: 10.1016/j.breast.2016.12.018. Epub 2017 Jan 5. Breast. 2017. PMID: 28064072
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Graziano V, Grassadonia A, Iezzi L, Vici P, Pizzuti L, Barba M, Quinzii A, Camplese A, Di Marino P, Peri M, Veschi S, Alberti S, Gamucci T, Di Gioacchino M, De Tursi M, Natoli C, Tinari N. Graziano V, et al. Breast. 2019 Apr;44:33-38. doi: 10.1016/j.breast.2018.12.014. Epub 2019 Jan 2. Breast. 2019. PMID: 30611095
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.
Gamucci T, Pizzuti L, Natoli C, Mentuccia L, Sperduti I, Barba M, Sergi D, Iezzi L, Maugeri-Saccà M, Vaccaro A, Magnolfi E, Gelibter A, Barchiesi G, Magri V, D'Onofrio L, Cassano A, Rossi E, Botticelli A, Moscetti L, Omarini C, Fabbri MA, Scinto AF, Corsi D, Carbognin L, Mazzotta M, Bria E, Foglietta J, Samaritani R, Garufi C, Mariani L, Barni S, Mirabelli R, Sarmiento R, Graziano V, Santini D, Marchetti P, Tonini G, Di Lauro L, Sanguineti G, Paoletti G, Tomao S, De Maria R, Veltri E, Paris I, Giotta F, Latorre A, Giordano A, Ciliberto G, Vici P. Gamucci T, et al. Among authors: graziano v. Cancer Biol Ther. 2019;20(2):192-200. doi: 10.1080/15384047.2018.1523095. Epub 2018 Nov 7. Cancer Biol Ther. 2019. PMID: 30403909 Free PMC article.
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression.
Grassadonia A, Graziano V, Pagotto S, Veronese A, Giuliani C, Marchisio M, Lanuti P, De Tursi M, D'Egidio M, Di Marino P, Brocco D, Vici P, De Lellis L, Cama A, Natoli C, Tinari N. Grassadonia A, et al. Among authors: graziano v. Cell Death Discov. 2021 Apr 22;7(1):86. doi: 10.1038/s41420-021-00469-1. Cell Death Discov. 2021. PMID: 33888686 Free PMC article.
Correction: Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression.
Grassadonia A, Graziano V, Pagotto S, Veronese A, Giuliani C, Marchisio M, Lanuti P, De Tursi M, D'Egidio M, Di Marino P, Brocco D, Vici P, De Lellis L, Cama A, Natoli C, Tinari N. Grassadonia A, et al. Among authors: graziano v. Cell Death Discov. 2021 May 11;7(1):100. doi: 10.1038/s41420-021-00490-4. Cell Death Discov. 2021. PMID: 33976112 Free PMC article. No abstract available.
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation.
Brocco D, Lanuti P, Simeone P, Bologna G, Pieragostino D, Cufaro MC, Graziano V, Peri M, Di Marino P, De Tursi M, Grassadonia A, Rapposelli IG, Pierdomenico L, Ercolino E, Ciccocioppo F, Del Boccio P, Marchisio M, Natoli C, Miscia S, Tinari N. Brocco D, et al. Among authors: graziano v. J Oncol. 2019 Nov 18;2019:5879616. doi: 10.1155/2019/5879616. eCollection 2019. J Oncol. 2019. PMID: 31827511 Free PMC article.
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation".
Brocco D, Lanuti P, Simeone P, Bologna G, Pieragostino D, Cufaro MC, Graziano V, Peri M, Di Marino P, De Tursi M, Grassadonia A, Rapposelli IG, Pierdomenico L, Ercolino E, Ciccocioppo F, Del Boccio P, Marchisio M, Natoli C, Miscia S, Tinari N. Brocco D, et al. Among authors: graziano v. J Oncol. 2020 Mar 31;2020:8947367. doi: 10.1155/2020/8947367. eCollection 2020. J Oncol. 2020. PMID: 32318109 Free PMC article.
137 results